Featured Research

from universities, journals, and other organizations

X Marks The Spot: Vector Insertion Is Viral Specific

Date:
August 17, 2004
Source:
University Of Pennsylvania Medical Center
Summary:
Researchers at the University of Pennsylvania School of Medicine have completed the first whole-genome survey of where three commonly used retroviruses integrate into human DNA.

Integration sites in the human genome. HIV integation sites shown as blue "lollipops"; MLV integration sites shown in lavender; and ASLV integration sites shown in green in each of the numbered human chromosomes.
Credit: R.S. Mitchell, B.F. Beitzel, A.R.W. Schroder, P. Shinn, H. Chen, C.C. Berry, J.R. Ecker, F.D. Bushman/PLoS Biology

Philadelphia, PA -- Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients. Viruses integrate into host DNA to replicate, but exactly where they insert themselves has become a topic of increasing importance. This is of special concern when integration is near an oncogene that may lead to uncontrolled, cancerous cell growth.

Related Articles


Now, researchers at the University of Pennsylvania School of Medicine have completed the first whole-genome survey of where three commonly used retroviruses integrate into human DNA. The team, led by Frederic Bushman, PhD, Professor of Microbiology, compared vectors derived from human immunodeficiency virus (HIV), murine leukemia virus (MLV), and avian sarcoma-leukosis virus (ASLV). They found that HIV integrated near active genes; MLV near points on the chromosome where protein translation starts (which confirms earlier work by another lab); and ASLV integrated more randomly throughout the entire genome. That each studied virus preferred a unique integration pattern or site suggests that viruses home in on certain chromosomal features for inserting themselves within the genome. This work appears in the August 17 issue of PLoS Biology, a new open-access journal.

"There's a picture forming of where different retroviruses integrate in human cells, and it seems to be quite different from virus to virus, which is not something anyone would have ever suspected," says Bushman. "We can only speculate as to the mechanism at present, but one attractive idea is that retroviral-integration complexes bind to cellular DNA binding proteins attached to specific locations on chromosomes." For HIV, integrating into active genes may help promote efficient viral gene expression. The reason for the choice of target is less clear in other retroviruses.

These findings are important for devising safer human gene-therapy vehicles. From studies in yeast, the researchers speculate that there is a system of biochemical recognition between proteins bound on human chromosomes and viral proteins, which helps guide integration, and that specific recognition seems to differ from virus to virus. "There's a prospect of modulating or engineering that kind of system, once we understand it better to direct integration to different locations," comments Bushman.

These findings can also help researchers understand how HIV enters cells in order to devise drugs to block that entry. "If there's a key interaction required for growth of a virus, then that would be a target to inhibit," says Bushman. HIV needs three enzymes - reverse transcriptase, protease, and integrase - to complete a full replication cycle. AZT and protease inhibitors stop activity of the first two, respectively, and the last one left to target is integrase, the object of a new AIDS drug recently tested in rhesus monkeys. "If there is a 'targeting factor' required for efficient replication, then blocking its function might obstruct viral replication," says Bushman. "The clearest way forward is to inhibit the catalytic activity of the integrase protein and some of our future work is geared toward that."

These are still early days in harnessing knowledge about viral integration in humans to make safer and more effective gene therapies, let alone new drugs against HIV. To that end, new information on targeting integration is likely to help guide design of better therapy, say the researchers.

Other members of the research team included Penn colleagues Rick S. Mitchell, Brett F.Beitzel, and Astrid R.W. Schroder, as well as Paul P. Shinn, Huaming Chen, and Joe R. Ecker from The Salk Institute and Charles C. Berry from the University of California at San Diego School of Medicine. This research was funded by the James B. Pendleton Charitable Trust, the Berger Foundation, and the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "X Marks The Spot: Vector Insertion Is Viral Specific." ScienceDaily. ScienceDaily, 17 August 2004. <www.sciencedaily.com/releases/2004/08/040817081357.htm>.
University Of Pennsylvania Medical Center. (2004, August 17). X Marks The Spot: Vector Insertion Is Viral Specific. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2004/08/040817081357.htm
University Of Pennsylvania Medical Center. "X Marks The Spot: Vector Insertion Is Viral Specific." ScienceDaily. www.sciencedaily.com/releases/2004/08/040817081357.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins